Abstract 520
Background
To evaluate the prognostic value of the proposed 8th Edition of the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) staging system for nasopharyngeal carcinoma (NPC) patients without cervical lymph node metastasis in comparison with the AJCC/ UICC 7th edition.
Methods
This is a retrospective study of 382 newly diagnosed non-metastatic NPC patients without cervical Lymph node metastasis who were treated with intensity-modulated radiotherapy (IMRT). All received elective neck irradiation to levels II, III, VA. Univariate and multivariate analyses were applied to evaluate the prognostic values between adjacent stage categories of the AJCC/ UICC 7th edition and the proposed 8th edition, including overall survival (OS), local relapse-free survival (LRFS), regional relapse-free survival (RRFS), distant metastasis-free survival (DMFS), and disease–free survival (DFS). The Akaike information criterion (AIC) and Harrell’s concordance index (c-index) were applied to compare the two prognostic systems with different numbers of stages.
Results
The median follow-up time was 61.1 months, with a range from 1 months to 91 months. The 5-year OS, LRFS, RFFS, DMFS and DFS were 86.9%, 96.7%, 99.1%, 93.3% and 82.6%, respectively. For LRFS and DMFS, the proposed eighth editions had superior prognostic value to the AJCC/ UICC 7th edition (P = 0.032 vs. P = 0.086 and P = 0.013 vs. P = 0.112). The 5-year OS and DFS were found to be significant both by the seventh and the proposed 8th editions. The difference between T1 and T3, T1 and T4, T2 and T3 and T2 and T4 by the proposed eighth edition were found to be significant (P = 0.042, P = 0.041, P = 0.000, and P = 0.000), however, there was no significant difference between T1 and T3, T2 and T3 by the seventh edition (P = 0.204, and P = 0.215). In addition, the difference between T1, T2, T3 with T4 were found to be significant in DFS (P = 0.000, P = 0.000, P = 0.037) and there was no significant difference between T1 and T3 (P = 0.162) by the seventh edition and there was significantly different between T2 and T4 (P = 0.026) by the proposed 8th editions. Multivariate analysis demonstrated that age, T stage of the proposed 8th editions and chemotherapy were independent prognostic factors for OS, LRFS, DMFS and DFS. The AIC value was smaller for the 8th edition compared to the 7th edition staging system. The C-index value was larger for the 8th edition compared to the 7th edition staging system.
Conclusions
IMRT with elective neck irradiation provides excellent local-regional control for NPC patients without cervical lymph node metastasis. The proposed eighth editions had superior prognostic value to the AJCC/ UICC 7th edition for LRFS and DMFS and lead a better distinction between adjacent T stages of nasopharyngeal carcinoma patients for OS and DFS. Overall, the proposed 8th UICC T classification seems to be superior to the 7th UICC T classification for nasopharyngeal carcinoma patients without cervical lymph node metastasis.
Clinical trial identification
Legal entity responsible for the study
Fudan University Shanghai Cancer Center.
Funding
Has not received any funding.
Editorial Acknowledgement
Disclosure
The author has declared no conflicts of interest.
Resources from the same session
4162 - ODM-207 - a novel BET bromodomain inhibitor with antitumor activity in nonclinical models of ER+ breast cancer
Presenter: Anu Moilanen
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3747 - HER2-positive breast cancer resistance to trastuzumab is associated with metabolic switch.
Presenter: Roman Dubianski
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4688 - Combination treatment with the PARP inhibitor niraparib and chemotherapeutics in a preclinical model of KRAS/BRAF mutated colorectal cancer cell lines across the four Consensus Molecular Subtypes.
Presenter: Pietro Paolo Vitiello
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
498 - Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway.
Presenter: Xiao Fu
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3731 - Effect of the polymorphism rs2470893 of the CYP1A1 gene on ovarian and endometrial cancer in Mediterranean women
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1215 - Cisplatin in NIPEC or HIPEC?
Presenter: Ivan Alvovsky
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
2738 - Matrix metalloproteinase-mediated regulation of programmed-death ligand in the human head and neck squamous cell carcinoma microenvironment
Presenter: MARIKO HIRAI
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
2190 - Trametinib synergizes with dexamethasone in KRAS-mutant myeloma cell lines through modulation of NDRG1 and induction of apoptosis
Presenter: Priya Sriskandarajah
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4482 - Functional inhibition of TGF-_ in colorectal cancer cells and its interaction with AXL receptor
Presenter: Davide Ciardiello
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
624 - Isoform-specific AKT Inhibition Differentially Affects Cell Functions in Pancreatic Adenocarcinoma
Presenter: Hugo Arasanz
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract